These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1525707)
1. Endogenous production of specific antibodies does not decrease hypocalcemic response to calcitonin in young rabbits. Reginster JY; Azria M; Gaspar S; Bleicher M; Franchimont N; Behhar M; Albert A; Franchimont P Calcif Tissue Int; 1992 Jun; 50(6):518-20. PubMed ID: 1525707 [TBL] [Abstract][Full Text] [Related]
2. Hypocalcemic effect of salmon calcitonin following single and repeated nasal and intravenous administration in young rabbits. Schipper NG; Romeijn SG; Verhoef J; Merkus FW Calcif Tissue Int; 1994 Jan; 54(1):50-5. PubMed ID: 8118754 [TBL] [Abstract][Full Text] [Related]
3. Pharmacologic evaluation of the calcitonin analogue SB 205614 in models of osteoclastic bone resorption in vitro and in vivo: comparison with salmon calcitonin and elcatonin. McSheehy PM; Farina C; Airaghi R; Allievi E; Banfi S; Bertolini D; Ferni G; Frattola D; Oneta S; Pinza M Bone; 1995 Apr; 16(4):435-44. PubMed ID: 7605704 [TBL] [Abstract][Full Text] [Related]
4. Transdermal iontophoresis of salmon calcitonin can reproduce the hypocalcemic effect of intravenous administration. Santi P; Volpato NM; Bettini R; Catellani PL; Massimo G; Colombo P Farmaco; 1997; 52(6-7):445-8. PubMed ID: 9372596 [TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of myeloma osteoclastic bone lesions: II. Induced hypocalcemia test using salmon calcitonin. Bataille R; Sany J Metab Bone Dis Relat Res; 1982; 4(1):39-42. PubMed ID: 7121253 [TBL] [Abstract][Full Text] [Related]
6. Prevention of osteoporosis with nasal salmon calcitonin: effect of anti-salmon calcitonin antibody formation. Reginster JY; Gaspar S; Deroisy R; Zegels B; Franchimont P Osteoporos Int; 1993 Sep; 3(5):261-4. PubMed ID: 8400608 [TBL] [Abstract][Full Text] [Related]
7. A noncompetitive enzyme immunoassay (hetero-two-site enzyme immunoassay) for salmon calcitonin: determination of the bioavailability of subcutaneous salmon calcitonin and its correlation with the hypocalcemic activity in rats. Kohno T; Nakamuta H; Ichikawa M; Watabe K; Koida M J Clin Lab Anal; 1996; 10(2):91-7. PubMed ID: 8852361 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin. Muff R; Dambacher MA; Perrenoud A; Simon C; Fischer JA Am J Med; 1990 Aug; 89(2):181-4. PubMed ID: 2382666 [TBL] [Abstract][Full Text] [Related]
9. Induction of hypocalcemia by intracerebroventricular injection of calcitonin: evidence for control of blood calcium by the nervous system. Goltzman D; Tannenbaum GS Brain Res; 1987 Jul; 416(1):1-6. PubMed ID: 3620946 [TBL] [Abstract][Full Text] [Related]
10. Intranasal delivery of PEGylated salmon calcitonins: hypocalcemic effects in rats. Lee KC; Park MO; Na DH; Youn YS; Lee SD; Yoo SD; Lee HS; DeLuca PP Calcif Tissue Int; 2003 Dec; 73(6):545-9. PubMed ID: 14508623 [TBL] [Abstract][Full Text] [Related]
11. Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate. Delmas PD; Chapuy MC; Meunier PJ Horm Metab Res; 1984 May; 16(5):258-61. PubMed ID: 6234216 [TBL] [Abstract][Full Text] [Related]
12. Salmon calcitonin treatment by nasal spray in primary hyperparathyroidism. Tørring O; Bucht E; Sjöstedt U; Sjöberg HE Bone; 1991; 12(5):311-6. PubMed ID: 1782100 [TBL] [Abstract][Full Text] [Related]
13. [Centrally and peripherally induced anorectic actions of salmon calcitonin (sCT) in rats: separation of its novel derivative [Gly8]-sCT]. Nakamuta H; Koida M; Ogawa Y; Orlowski RC Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):191-5. PubMed ID: 3038715 [TBL] [Abstract][Full Text] [Related]
14. Studies on the hypocalcemic actions of salmon calcitonin and ultimobranchial gland extracts in the freshwater teleost Cyprinus carpio. Chakrabarti P; Mukherjee D Gen Comp Endocrinol; 1993 Jun; 90(3):267-73. PubMed ID: 8224753 [TBL] [Abstract][Full Text] [Related]
15. Human calcitonin has the same inhibitory effect on osteoclastic bone resorption by human giant cell tumor cells as salmon calcitonin. Iida S; Kakudo S; Mori Y; Matsui M; Magota K; Kitajima Y; Nakamura N; Mano H; Hakeda Y; Azuma H; Kurokawa T; Kumegawa M Calcif Tissue Int; 1996 Aug; 59(2):100-4. PubMed ID: 8687977 [TBL] [Abstract][Full Text] [Related]
16. Acute effects of salmon calcitonin in multiple myeloma: a valuable method for serial evaluation of osteoclastic lesions and disease activity--a prospective study of 125 patients. Bataille R; Legendre C; Sany J J Clin Oncol; 1985 Feb; 3(2):229-36. PubMed ID: 3968553 [TBL] [Abstract][Full Text] [Related]
18. Oral delivery of mono-PEGylated sCT (Lys18) in rats: regional difference in stability and hypocalcemic effect. Mansoor S; Youn YS; Lee KC Pharm Dev Technol; 2005; 10(3):389-96. PubMed ID: 16176019 [TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of salmon calcitonin-sodium triphosphate ionic complex for oral delivery. Lee HE; Lee MJ; Park CR; Kim AY; Chun KH; Hwang HJ; Oh DH; Jeon SO; Kang JS; Jung TS; Choi GJ; Lee S J Control Release; 2010 Apr; 143(2):251-7. PubMed ID: 20026364 [TBL] [Abstract][Full Text] [Related]
20. Effect of rate of calcium reduction and a hypocalcemic clamp on parathyroid hormone secretion: a study in dogs. Estepa JC; Aguilera-Tejero E; Almaden Y; Rodriguez M; Felsenfeld AJ Kidney Int; 1999 May; 55(5):1724-33. PubMed ID: 10231434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]